73 related articles for article (PubMed ID: 9390033)
1. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens.
Verbeek BS; Adriaansen-Slot SS; Rijksen G; Vroom TM
J Pathol; 1997 Oct; 183(2):195-203. PubMed ID: 9390033
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Grb2 gene in human breast cancer cell lines.
Daly RJ; Binder MD; Sutherland RL
Oncogene; 1994 Sep; 9(9):2723-7. PubMed ID: 8058337
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
Tari AM; Hung MC; Li K; Lopez-Berestein G
Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
[TBL] [Abstract][Full Text] [Related]
4. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
5. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis.
Verbeek BS; Vroom TM; Adriaansen-Slot SS; Ottenhoff-Kalff AE; Geertzema JG; Hennipman A; Rijksen G
J Pathol; 1996 Dec; 180(4):383-8. PubMed ID: 9014858
[TBL] [Abstract][Full Text] [Related]
6. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
7. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
[TBL] [Abstract][Full Text] [Related]
8. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
[TBL] [Abstract][Full Text] [Related]
10. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
11. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
13. A role for the scaffolding adapter GAB2 in breast cancer.
Bentires-Alj M; Gil SG; Chan R; Wang ZC; Wang Y; Imanaka N; Harris LN; Richardson A; Neel BG; Gu H
Nat Med; 2006 Jan; 12(1):114-21. PubMed ID: 16369543
[TBL] [Abstract][Full Text] [Related]
14. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
[TBL] [Abstract][Full Text] [Related]
15. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue.
Downey SE; Hoyland J; Freemont AJ; Knox F; Walls J; Bundred NJ
J Pathol; 1997 Oct; 183(2):212-7. PubMed ID: 9390035
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients.
Niewiadomska H; Mirowski M; Stempień M; Błoński JZ; Czyz W; Switalska J; Matyga E; Hanausek M; Wierzbicki R
Neoplasma; 2000; 47(1):8-14. PubMed ID: 10870681
[TBL] [Abstract][Full Text] [Related]
18. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer.
Daly RJ; Gu H; Parmar J; Malaney S; Lyons RJ; Kairouz R; Head DR; Henshall SM; Neel BG; Sutherland RL
Oncogene; 2002 Aug; 21(33):5175-81. PubMed ID: 12140767
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
